Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MAPKAPK2 | P49137 | 8/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.39 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.39 |
| ▸ | HTR3B | O95264 | 2/20 | 0.39 |
| ▸ | HTR3A | P46098 | 2/20 | 0.39 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.39 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18910226 | 0.96 | ADRB1 (0.48) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL23152941 | 0.96 | MAPKAPK2 (0.50) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL17269404 | 0.94 | HPGD (0.44) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL19601159 | 0.94 | LMNA (0.43) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL4473427 | 0.94 | ALDH1A1 (0.51) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL21477316 | 0.93 | MAPKAPK2 (0.41) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL17269410 | 0.93 | POLB (0.43) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL17269417 | 0.92 | CHRNA10 (0.46) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL20988009 | 0.92 | CHRNA10 (0.42) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 | |
| SCHEMBL18910121 | 0.91 | ALDH1A1 (0.50) | ALDH1A1USP2TSHRHSD17B10MAPKAPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674089-B2 | Michael addition reaction product and active energy ray-curable composition | DIC CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8674089-B2 | Michael addition reaction product and active energy ray-curable composition | DIC CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| US-8674089-B2 | Michael addition reaction product and active energy ray-curable composition | DIC CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| EP-2450344-B1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DAINIPPON INK & CHEMICALS (JP) | 2013-12-11 | — | — | EP | disclosed |
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DIC CORPORATION. (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DIC CORPORATION. (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DIC CORPORATION. (JP) | 2012-07-26 | — | — | US | disclosed |
| EP-2450344-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | DIC Corporation (JP) | 2012-05-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190846-A1 | MICHAEL ADDITION REACTION PRODUCT AND ACTIVE ENERGY RAY-CURABLE COMPOSITION | PARP14, TIPARP, PARP16 | ALDH1A1 590/4885USP2 3914/4885TSHR 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.